|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1991-6-6
|
|
pubmed:abstractText |
Intraperitoneal radioactive chromic phosphate was administered to 69 patients with Stage I and II ovarian carcinoma who had undergone comprehensive surgical staging. Intestinal obstruction requiring surgical intervention occurred in four patients and was the most severe complication. Abdominal pain was the most common post-therapy complaint. Attention to time and technique of drug administration could minimize complications.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
939-44
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:2022522-Adolescent,
pubmed-meshheading:2022522-Adult,
pubmed-meshheading:2022522-Aged,
pubmed-meshheading:2022522-Chromium,
pubmed-meshheading:2022522-Chromium Compounds,
pubmed-meshheading:2022522-Female,
pubmed-meshheading:2022522-Follow-Up Studies,
pubmed-meshheading:2022522-Humans,
pubmed-meshheading:2022522-Injections, Intraperitoneal,
pubmed-meshheading:2022522-Melphalan,
pubmed-meshheading:2022522-Middle Aged,
pubmed-meshheading:2022522-Ovarian Neoplasms,
pubmed-meshheading:2022522-Phosphates,
pubmed-meshheading:2022522-Phosphorus Radioisotopes,
pubmed-meshheading:2022522-Prospective Studies,
pubmed-meshheading:2022522-Radiotherapy
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill 27599-7570.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Review
|
